S1C(R2) Dose Selection for Carcinogenicity Studies of Pharmaceuticals
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 17, 2008
April 23, 2020
2a345429-ca02-44f7-82b1-69aca91cb8e5
Related Documents
E15 Pharmacogenomics Definitions and Sample Coding
Guidance DocumentApril 8, 2008Center for Drug Evaluation and Research
Q10 Pharmaceutical Quality System
Guidance DocumentApril 8, 2009Center for Drug Evaluation and Research
Q3A(R) Impurities in New Drug Substances
Guidance DocumentJune 6, 2008Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.